102 Annual Pap Smear Screening Database Maintenance Project

N/AUnknownNCT02063152

National Taiwan University Hospital300,000 enrolled

Overview

This study aimed to evaluate the subsequent cancer risks, including gynecological cancers and malignancies at other sites, after the detection of screening positives and the diagnosis for primary cervical cancer.

Study Type

OBSERVATIONAL

Enrollment

300,000

Conditions

Cancer Human Papillomavirus

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 130 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Citizens in Taiwan * Women who attended screening, or who were diagnosed as cervical cancer * Women who did not attend screening for at least 6 years Exclusion Criteria: * Women died before the follow-up initiation * Women who had received hysterectomy before the follow-up initiation

Locations (1)

Taiwan Cervical Cancer Prevention Monitoring Center

Taipei, Taiwan

RECRUITING

Outcomes

Primary Outcomes

Time to the cancer diagnosis or the recurrence, the death, or the last date of follow-up, whichever came first

Time frame: up to 25 years

Central Contacts

Hui-Chi Chen, PhD

CONTACT

+886 2 23910409 d90842001@ntu.edu.tw

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.